Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
Atrial fibrillation is now recognized as a significant medical and social problem. Atrial fibrillation not only causes cardiovascular complications, including thromboembolism and heart failure, but also decreases the survival of patients with impaired left ventricular function; thus, it is considere...
Main Author: | Takashi Komatsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-06-01
|
Series: | Journal of Arrhythmia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427612000828 |
Similar Items
-
Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01) -
Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
by: Meng Geng, et al.
Published: (2020-11-01) -
ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01) -
Efficacy of Long-term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation —Analysis Based on Time of Onset—
by: Takashi Komatsu, MD, et al.
Published: (2006-01-01) -
Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects
by: M. G Bubnova, et al.
Published: (2015-09-01)